Hosted by Eileen Scully, MD, PhD, and Christopher Hoffmann, MD, MSC, MPH, both HIV specialists at Johns Hopkins, Viremic explores quandaries in adult HIV care. Each case discussion includes medical history and diagnoses, challenges in care and treatment, and key evidence and guidelines that informed clinical decision‑making.
Cases are presented as a composite from the hosts’ clinical practice, with all identifying details removed to protect the privacy of patients. Case discussions are for informational purposes only and not offered as medical or clinical practice advice for patients or clinicians. Any mention of specific medications or commercially available products is a description of use only, not an endorsement. Viremic is produced by the Clinical Guidelines Program, a collaborative effort of the New York State Department of Health AIDS Institute and the Johns Hopkins University Division of Infectious Diseases.

Do you have comments or suggestions for future case topics?
Email us at viremicpodcast@jh.edu. Please note that we cannot reply to questions about specific cases or medical conditions.

Latest Episodes

Case 33. IRIS – Bumps Along the Road to Recovery

A 30-year-old bisexual man is hospitalized and diagnosed with advanced HIV disease and presumptive Pneumocystis pneumonia (PCP). He has an initial CD4 cell count of 34...

Case 32. Nonsuppressible Viremia: When Undetectable Is Unachievable

A 45-year-old male patient with HIV and a history of sustained viral suppression suddenly has detectable viremia that persists for more than 12 months (range 80 to 250...

Case 31. bNAbs – Will They Be Broadly Used?

A patient asks, “Can I get the every-six-month treatment?” Listen as Eileen Scully and Chris Hoffmann of Johns Hopkins review recent study results on HIV treatment wit...

Case 30. Problem Solving with New ARVs

A 43-year-old man with HIV is virally suppressed on Odefsey. He started Biktarvy 5 years ago but was switched because of headaches. He recently developed worsening kid...

Case 29. U=U: Living a New Normal

A 48-year-old man with HIV that is well-controlled on dolutegravir/lamivudine has met someone and they are starting to date. His partner is HIV-seronegative, and they ...

More Episodes »
Broadcast by